Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

LeMaitre Vascular, Inc. LMAT

Set alert

Price alert · LMAT

All alert types
81.26 USD +0.32 +0.40%

At close · Nov 2

80.44 -0.82 -1.01%

After hours · Nov 2, 4:00 PM ET

Bid
81.20 × 1
Ask
81.27 × 2
80.80 Day range 82.38
78.22 52-week range 118.01
YTD
+0.20%
1 year
-6.18%
Open
82.06
Prev close
80.94
Mkt cap
1.86B
Vol
270.73K
Avg vol
328.28K
EPS
2.85
P/E
28.51
Div yield
1.17%
More statistics
Low
80.80
High
82.38
Forward P/E
25.56
Beta
0.49
Short ratio
6.66
Inst. own
105.32%
Dividend
1.00
Ex-div date
Aug 19, 2026
Earnings
Nov 4, 2026
50-d avg
81.20
200-d avg
94.47
1y target
107.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Earnings: 0.74; estimate 0.807; surprise -8.3%
  • Aug 5, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
  • Aug 20, 2026Dividend: 0.25
Signals (19)
NameDateAgo
SMA: BullishNov 2, 202621 hours ago
MACD: Sell SignalNov 2, 202621 hours ago
SMA: BearishOct 30, 20263 days ago
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 19, 20262 weeks ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 6, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 24, 20261 month ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 22, 20261 month ago
MACD: Buy SignalAug 28, 20262 months ago
SMA: BearishAug 5, 20262 months ago
SMA: BearishAug 5, 20262 months ago
MACD: Sell SignalAug 5, 20262 months ago
RSI: OversoldAug 5, 20262 months ago

Analyst view

Consensus: buy

Buy
Price target (mean) 107.00 +31.7% upside
Target (low)
81.00
Target (mean)
107.00
Target (high)
132.00
Ratings (0m) 8 4 buy · 4 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

LMAT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.686250.68 – 0.690.75-8.5%67.37M+10.4%8
Next quarter0.77750.77 – 0.790.68+14.3%72.24M+12.1%8
Current year2.882.84 – 2.902.52+14.2%276.53M+10.8%8
Next year3.183.04 – 3.302.88+10.4%302.95M+9.6%8

Upgrades and downgrades

The latest rating changes

LMAT analyst upgrades and downgrades
DateFirmActionFromTo
Aug 5, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Jun 3, 2026Barrington ResearchMaintainedOutperformOutperform
May 6, 2026Barrington ResearchMaintainedOutperformOutperform
May 6, 2026CitizensMaintainedMarket OutperformMarket Outperform
May 6, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Feb 26, 2026Barrington ResearchMaintainedOutperformOutperform
Feb 26, 2026Roth CapitalReiteratedBuyBuy
Feb 26, 2026Wells FargoMaintainedEqual-WeightEqual-Weight
Feb 26, 2026CitizensMaintainedMarket OutperformMarket Outperform
Feb 20, 2026Barrington ResearchMaintainedOutperformOutperform
Nov 7, 2025Wells FargoMaintainedEqual-WeightEqual-Weight
Oct 15, 2025Barrington ResearchMaintainedOutperformOutperform
Sep 23, 2025Barrington ResearchMaintainedOutperformOutperform
Aug 6, 2025Cantor FitzgeraldMaintainedNeutralNeutral
Aug 6, 2025Barrington ResearchUpgradeMarket PerformOutperform
Jul 22, 2025Barrington ResearchReiteratedMarket PerformMarket Perform
Feb 28, 2025Lake StreetMaintainedBuyBuy
Feb 28, 2025Citizens Capital MarketsMaintainedBuyBuy
Feb 28, 2025Barrington ResearchDowngradeOutperformMarket Perform
Feb 13, 2025Wells FargoInitiated—Equal-Weight
Nov 1, 2024OppenheimerReiteratedOutperformOutperform
Nov 1, 2024Barrington ResearchMaintainedOutperformOutperform
Oct 15, 2024Cantor FitzgeraldInitiated—Neutral
Sep 20, 2024Barrington ResearchMaintainedOutperformOutperform
Aug 20, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Aug 2, 2024Barrington ResearchMaintainedOutperformOutperform
May 3, 2024Barrington ResearchMaintainedOutperformOutperform
May 3, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Apr 26, 2024StifelUpgradeHoldBuy
Feb 28, 2024Barrington ResearchMaintainedOutperformOutperform